MedTrace Logo

Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer

NCT03328559 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-08-23

No results posted yet for this study

Summary

The pronostic value of Circulating Tumoral Cells(CTC) 's dosage by the method ISET® (tumoral cell isolation by size) in patients with bronchial cancer was previously demonstrated.

However, no kinetic study was ever realized to study the value of the CTC as predictive indicator of answer to the therapy. This project plans to study patients in an early stage and patients at advance stage locally moved forward or metastatic of the disease by evaluation of the presence and the number of CTC before every cure. This collaborative and original study should allow to refine the diagnoses of answer and to plan the possible relapses what would allow a premature institution of the treatment.

Conditions

  • Bronchial Cancer

Interventions

DIAGNOSTIC_TEST

ISET® - Isolation by Size of Tumor cells

early stage bronchial cancer patient will have a blood collection

DIAGNOSTIC_TEST

ISET® - Isolation by Size of Tumor cells

advanced stage bronchial cancer patient will have a blood collection

Sponsors & Collaborators

  • Fondation Hôpital Saint-Joseph

    lead OTHER

Principal Investigators

  • Jean P Tredaniel, Pr · Fondation Hôpital Saint-Joseph

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-07
Primary Completion
2018-11-30
Completion
2021-08-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03328559 on ClinicalTrials.gov